ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Ultragenyx Pharmaceutical INC.

Official 2024 U.S. DOL Form 5500 summary for Ultragenyx Pharmaceutical INC. (Ultragenyx Pharmaceutical INC. 401(k) Plan And Trust · EIN 27-2546083 · PN 001): $217.92M net assets, 1,082 active participants, and $5.72 per $10,000 (5.72 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorUltragenyx Pharmaceutical INC.
Filing IdentifierUltragenyx Pharmaceutical INC. 401(k) Plan And Trust · EIN 27-2546083 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$100M-$500M
Plan Net Assets (2024)$217.92M
Active Participants1,082
Direct Admin Fee Rate$5.72 per $10,000 (5.72 bps)
Cohort Peer Median$9.75 per $10,000 (9.75 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI

Cross-Agency Entity Graph

Related Filings Across Meru Platforms

Verified federal filings reconciled for Ultragenyx Pharmaceutical across sibling Meru AI platforms.